Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs Marek Health

Claya
Graded #267

Lower grade

vs+4.1000000000000085
Marek Health
Graded #181

Higher grade

The verdict

Marek Health takes it — 66.9/100 to 62.8/100.

Marek Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Marek Health is a performance-focused telehealth platform pairing US clients with partnered physicians and health coaches for GLP-1 weight-loss therapy (semaglutide and tirzepatide), comprehensive lab…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMarek Health +3
42
45
Dose & formulationClaya +35
75
40
Clinical oversightMarek Health +11
82
93
Labs & monitoringMarek Health +44
53
97
FulfillmentMarek Health +17
67
84
Contract termsClaya +6
61
55
Claya · left barMarek Health · right bar

The numbers

MetricClayaMarek Health
WeighScore62.8/10066.9/100
GradeCC
Scorecard rank#267#181
Semaglutide$299/mo (compounded)Not disclosed
Tirzepatide$299/mo (compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Claya

Graded #267 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
Marek Health

Graded #181 · C

Strengths

  • Lab panels are core: initial comprehensive labs + 6–12 week follow-up + ongoing every 6 months — rare among GLP-1 providers
  • Dedicated Health Coach paired with each client alongside partnered licensed physician as standard Proactive Care Team
  • All 50 US states served; 100% telehealth with routine physician check-ins every 6 months built into the program
  • Human optimization framing attracts pragmatic patients; partnered physicians selected for data-driven, high-leverage mindset
  • No set subscription plan — custom protocol built around client health goals with option to cancel anytime

Where it loses points

  • Pricing fully gated — no published rates; intake assessment required before quotes, limiting upfront comparison shopping
  • Annual in-person physical required from own PCP or urgent care (every 12 months) — not provided by Marek Health
  • No LegitScript certification found; platform explicitly disclaims being a healthcare clinic, which reduces regulatory trust signals
  • Weight loss is one of many services alongside TRT, hair, brain focus, sexual health — not a dedicated GLP-1 platform
  • Compounded vs. brand medication details not disclosed publicly — medication type determined post-intake with partnered physician

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard